HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A triglycine linker improves tumor uptake and biodistributions of 67-Cu-labeled anti-neuroblastoma MAb chCE7 F(ab')2 fragments.

Abstract
The peptide-linked copper chelators CPTA-triglycyl-L-p-isothiocyanato-phenylalanine (CPTA-R1-NCS) as well as DOTA-triglycyl-L-p-isocyanato-phenylalanine (DOTA-R1-NCS) were synthesized and coupled to F(ab')2 fragments of the anti-neuroblastoma monoclonal antibody (MAb) chCE7. 67Cu-labeled conjugates were compared with the original CPTA- and DO3A-F(ab')2 in vitro and in vivo in mice bearing neuroblastoma xenografts. With the CPTA-R1-F(ab')2, biodistributions were improved, because radioactivity present in the kidney was reduced. With the DOTA-R1-F(ab')2, clearance from the blood was slower and tumor uptake was higher compared with the other conjugates. DOTA-R1-F(ab')2 achieved the best tumor/tissue ratios.
AuthorsK Zimmermann, S Gianollini, P A Schubiger, I Novak-Hofer
JournalNuclear medicine and biology (Nucl Med Biol) Vol. 26 Issue 8 Pg. 943-50 (Nov 1999) ISSN: 0969-8051 [Print] United States
PMID10708309 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Copper Radioisotopes
  • Immunoconjugates
  • Immunoglobulin Fab Fragments
  • Ligands
  • Oligopeptides
  • Radiopharmaceuticals
  • glycyl-glycyl-glycine
Topics
  • Animals
  • Antibodies, Monoclonal (chemistry, pharmacokinetics)
  • Brain Neoplasms (metabolism)
  • Chromatography, Gel
  • Chromatography, High Pressure Liquid
  • Chromatography, Thin Layer
  • Copper Radioisotopes
  • Humans
  • Immunoconjugates (chemistry, pharmacokinetics)
  • Immunoglobulin Fab Fragments (chemistry)
  • Ligands
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neuroblastoma (metabolism)
  • Oligopeptides (chemistry)
  • Radiopharmaceuticals (chemistry, pharmacokinetics)
  • Spectrophotometry, Ultraviolet
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: